Author:
Zhang Emily X.,Yazdi Cyrus,Islam Rahib K.,Anwar Ahmed I.,Alvares-Amado Alana,Townsend Horace,Allen Kaitlyn E.,Plakotaris Elena,Hirsch Jon D.,Rieger Ross G.,Allampalli Varsha,Hasoon Jamal,Islam Kazi N.,Shekoohi Sahar,Kaye Alan D.,Robinson Christopher L.
Publisher
Springer Science and Business Media LLC
Reference39 articles.
1. Feldman EL, Callaghan BC, Pop-Busui R, Zochodne DW, Wright DE, Bennett DL, et al. Diabetic neuropathy. Nat Rev Dis Primers. 2019;5:41. Comprehensive review on diabetic neuropathy.
2. Taylor RS, Lad SP, White JL, Stauss TG, Healey BE, Sacks NC, et al. Health care resource utilization and costs in patients with painful diabetic neuropathy treated with 10 kHz spinal cord stimulation therapy. J Manag Care Spec Pharm. 2023;29:1021–9. Utilization of SCS resulted in lower rates of hospitalization and consequently lower health care costs.
3. Pop-Busui R, Boulton AJM, Feldman EL, Bril V, Freeman R, Malik RA, et al. Diabetic neuropathy: a position statement by the American Diabetes Association. Diabetes Care. 2017;40:136–54.
4. Albers JW, Pop-Busui R. Diabetic neuropathy: Mechanisms, emerging treatments, and subtypes. Curr Neurol Neurosci Rep. 2014;14:473.
5. Hicks CW, Selvin E. Epidemiology of peripheral neuropathy and lower extremity disease in diabetes. Curr Diab Rep. 2019;19:86.